These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 28079846)

  • 41. Phenotypic characteristics associated with slow gait speed in idiopathic pulmonary fibrosis.
    Nolan CM; Maddocks M; Maher TM; Canavan JL; Jones SE; Barker RE; Patel S; Jacob J; Cullinan P; Man WD
    Respirology; 2018 May; 23(5):498-506. PubMed ID: 29139195
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Feasibility of a telehealth breathing intervention for patients with idiopathic pulmonary fibrosis.
    Bussa-Carlson A; Morrison H; Taylor-Piliae R; Shea K
    Appl Nurs Res; 2024 Oct; 79():151827. PubMed ID: 39256010
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Disease Severity and Quality of Life in Patients With Idiopathic Pulmonary Fibrosis: A Cross-Sectional Analysis of the IPF-PRO Registry.
    O'Brien EC; Hellkamp AS; Neely ML; Swaminathan A; Bender S; Snyder LD; Culver DA; Conoscenti CS; Todd JL; Palmer SM; Leonard TB;
    Chest; 2020 May; 157(5):1188-1198. PubMed ID: 31954102
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ambulatory oxygen in fibrotic lung disease (AmbOx): study protocol for a randomised controlled trial.
    Visca D; Tsipouri V; Mori L; Firouzi A; Fleming S; Farquhar M; Leung E; Maher TM; Cullinan P; Hopkinson N; Wells AU; Banya W; Whitty JA; Adamali H; Spencer LG; Sestini P; Renzoni EA
    Trials; 2017 Apr; 18(1):201. PubMed ID: 28454553
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Physical Inactivity in Pulmonary Sarcoidosis.
    Cho PSP; Vasudevan S; Maddocks M; Spinou A; Chamberlain Mitchell S; Wood C; Jolley CJ; Birring SS
    Lung; 2019 Jun; 197(3):285-293. PubMed ID: 30888492
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Health-related quality of life and symptoms in patients with IPF treated with nintedanib: analyses of patient-reported outcomes from the INPULSIS® trials.
    Kreuter M; Wuyts WA; Wijsenbeek M; Bajwah S; Maher TM; Stowasser S; Male N; Stansen W; Schoof N; Orsatti L; Swigris J
    Respir Res; 2020 Jan; 21(1):36. PubMed ID: 32000772
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The UCSD shortness of breath questionnaire has longitudinal construct validity in idiopathic pulmonary fibrosis.
    Swigris JJ; Han M; Vij R; Noth I; Eisenstein EL; Anstrom KJ; Brown KK; Fairclough D
    Respir Med; 2012 Oct; 106(10):1447-55. PubMed ID: 22801586
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effects of fatigue, pain, and depression on quality of life in ischemic stroke patients: the Bergen Stroke Study.
    Naess H; Lunde L; Brogger J
    Vasc Health Risk Manag; 2012; 8():407-13. PubMed ID: 22910531
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of obesity on patient-reported outcomes in sarcoidosis.
    Gvozdenovic BS; Mihailovic-Vucinic V; Vukovic M; Lower EE; Baughman RP; Dudvarski-Ilic A; Zugic V; Popevic S; Videnovic-Ivanov J; Filipovic S; Stjepanovic M; Omcikus M
    Int J Tuberc Lung Dis; 2013 Apr; 17(4):559-64. PubMed ID: 23485390
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical Correlates of Reduced Physical Activity in Idiopathic Pulmonary Fibrosis.
    Bahmer T; Kirsten AM; Waschki B; Rabe KF; Magnussen H; Kirsten D; Gramm M; Hummler S; Brunnemer E; Kreuter M; Watz H
    Respiration; 2016; 91(6):497-502. PubMed ID: 27240427
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development and Initial Validation Analyses of the Living with Idiopathic Pulmonary Fibrosis Questionnaire.
    Swigris JJ; Andrae DA; Churney T; Johnson N; Scholand MB; White ES; Matsui A; Raimundo K; Evans CJ
    Am J Respir Crit Care Med; 2020 Dec; 202(12):1689-1697. PubMed ID: 32634038
    [No Abstract]   [Full Text] [Related]  

  • 52. Benefits of physical training in patients with idiopathic or end-stage sarcoidosis-related pulmonary fibrosis: a pilot study.
    Strookappe B; Elfferich M; Swigris J; Verschoof A; Veschakelen J; Knevel T; Drent M
    Sarcoidosis Vasc Diffuse Lung Dis; 2015 Jun; 32(1):43-52. PubMed ID: 26237355
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fatigue and health-related quality of life in patients with pulmonary sarcoidosis treated by oral Corticosteroids.
    Aggarwal AN; Sahu KK; Gupta D
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Aug; 33(2):124-9. PubMed ID: 27537714
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MRC chronic Dyspnea Scale: Relationships with cardiopulmonary exercise testing and 6-minute walk test in idiopathic pulmonary fibrosis patients: a prospective study.
    Manali ED; Lyberopoulos P; Triantafillidou C; Kolilekas LF; Sotiropoulou C; Milic-Emili J; Roussos C; Papiris SA
    BMC Pulm Med; 2010 May; 10():32. PubMed ID: 20509928
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of corticosteroids on quality of life in a sarcoidosis clinic: the results of a propensity analysis.
    Judson MA; Chaudhry H; Louis A; Lee K; Yucel R
    Respir Med; 2015 Apr; 109(4):526-31. PubMed ID: 25698652
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The clinical course of idiopathic pulmonary fibrosis and its association to quality of life over time: longitudinal data from the INSIGHTS-IPF registry.
    Kreuter M; Swigris J; Pittrow D; Geier S; Klotsche J; Prasse A; Wirtz H; Koschel D; Andreas S; Claussen M; Grohé C; Wilkens H; Hagmeyer L; Skowasch D; Meyer JF; Kirschner J; Gläser S; Kahn N; Welte T; Neurohr C; Schwaiblmair M; Held M; Bahmer T; Oqueka T; Frankenberger M; Behr J
    Respir Res; 2019 Mar; 20(1):59. PubMed ID: 30876420
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MRP14 is elevated in the bronchoalveolar lavage fluid of fibrosing interstitial lung diseases.
    Korthagen NM; Nagtegaal MM; van Moorsel CH; Kazemier KM; van den Bosch JM; Grutters JC
    Clin Exp Immunol; 2010 Aug; 161(2):342-7. PubMed ID: 20550547
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term effects of a 12-week exercise training program on clinical outcomes in idiopathic pulmonary fibrosis.
    Vainshelboim B; Oliveira J; Fox BD; Soreck Y; Fruchter O; Kramer MR
    Lung; 2015 Jun; 193(3):345-54. PubMed ID: 25731736
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Burden of idiopathic pulmonary fibrosis on patients' emotional well being and quality of life: a literature review.
    Antoniou K; Kamekis A; Symvoulakis EK; Kokosi M; Swigris JJ
    Curr Opin Pulm Med; 2020 Sep; 26(5):457-463. PubMed ID: 32701673
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The development and validation of the King's Sarcoidosis Questionnaire for the assessment of health status.
    Patel AS; Siegert RJ; Creamer D; Larkin G; Maher TM; Renzoni EA; Wells AU; Higginson IJ; Birring SS
    Thorax; 2013 Jan; 68(1):57-65. PubMed ID: 23065052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.